Article
SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain
19 Sept 2023
Abstract excerpt
The COVID-19 pandemic and SARS-CoV-2 variants have dramatically illustrated the need for a better understanding of antigen (epitope)-antibody (paratope) interactions. To gain insight into the immunogenic characteristics of epitopic sites (ES), we systematically investigated the structures of 340 Abs and 83 nanobodies (Nbs) complexed with the Receptor Binding Domain (RBD) of the SARS-CoV-2 spike protein. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
